Acme (ACU) Fair Value 2026

ACU · Household & Personal Products ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

8.8 /10

32 fundamental signals · 13 models active

Value Trap Risk

SAFE (10/100)

Quick Summary — As of 2026-07-13, Acme (ACU) trades at $47.09, approximately 105% above CirclFi’s Bayesian DCF fair value of $23.01. QOC: 8.8/10. Value Trap Risk: 10/100 (SAFE). 13/13 models active.

Key Facts

Ticker
ACU
Price
$47.09
Quality Score
8.8/10
Value Trap Risk
10/100
Models Active
13/13
Last Updated
Strength: Quality Score of 8.8/10 indicates strong fundamentals
Risk: Majority of models suggest overvaluation

Valuation Matrix

13 Intrinsic Value Models vs. Current Price ($47.09)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
High Conviction
$23.01 -51.1%
Earnings Power Value
High Conviction
$11.54 -75.5%
CUCE Ensemble
Low Conviction
$27.24 -42.1%
First Chicago
High Conviction
$28.56 -39.3%

Unlock the Full Matrix

Access 9 additional models including EROIC Spread, Markov DDM, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 13 Models →

Cancel anytime · No contracts · Instant access

What Is Acme (ACU) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, the balance of valuation evidence tilts cautious on Acme at its current price of $47.09. The composite intrinsic value is estimated at $33.52 (-28.8% average return), with 9 models flagging overvaluation risk. Notably, Markov DDM sees the most upside at +92.5% (fair value: $90.66), while EPV is the most conservative at -75.5% ($11.54). The spread between these extremes — +168.0% — reveals how different analytical frameworks can reach starkly different conclusions. Among models with highest confidence, Bayesian DCF, EPV lean bearish — adding weight to the bearish side of the thesis.

What Do the Models Say About ACU?

13 of 13 models are currently active for ACU. Of these, 3 models suggest upside while 10 models suggest overvaluation. The Bayesian DCF estimates ACU's intrinsic value at $23.01, implying -51.1% downside from the current price. See which stocks rank higher →

How Does ACU Rank in Household & Personal Products?

Among 1 Household & Personal Products stocks, ACU ranks #1 by Quality of Company score. CirclFi's QOC score of 8.8/10 evaluates 32 fundamental signals. A score of 8.8 places ACU in the top tier.

Within the Household & Personal Products space, Acme competes in an environment where same-store sales growth (comps) often separates market leaders from laggards. Understanding these industry-specific dynamics is essential context for interpreting our model outputs.

Is ACU a Value Trap?

CirclFi's Value Trap algorithm assigns ACU a score of 10/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

13 of 13 models are active for Acme. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, Acme's fundamental quality profile registers 8.8/10. This robust score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

The gap between the most bullish and bearish model spans +168.0% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every ACU valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across ACU's 13 active models, average confidence is 53%. Moderate confidence indicates reasonable fit.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Acme Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Frequently Asked Questions About Acme

What is Acme's intrinsic value in 2026?

Based on CirclFi's 13-model analysis, Acme (ACU) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $23.01. The Quality of Company score is 8.8/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is ACU overvalued or undervalued right now?

At $47.09, 3 of 13 active models suggest ACU may be undervalued, while 10 indicate potential overvaluation. The assessment depends on which methodology best fits Acme's business model in Household & Personal Products.

What does a Quality of Company score of 8.8 mean for ACU?

Acme's QOC of 8.8/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on ACU?

CirclFi analyzes ACU with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 13 of 13 are active for this stock. Read the full methodology →

Is ACU a value trap in 2026?

Acme's Value Trap score is 10/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 13 mathematical frameworks give you clarity on ACU.

Unlock All 13 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access